当前位置:首页 - 行情中心 - 亚宝药业(600351) - 财务分析 - 现金流量表

亚宝药业

(600351)

  

流通市值:47.06亿  总市值:47.06亿
流通股本:6.92亿   总股本:6.92亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金523,132,410.532,154,303,813.941,639,675,251.491,129,022,660.04
  收到的税费返还2,761.061,125,612.88862,526.88583,589.32
  收到其他与经营活动有关的现金35,081,038.69149,998,947.87115,483,977.4165,433,405.35
  经营活动现金流入小计558,216,210.282,305,428,374.691,756,021,755.781,195,039,654.71
  购买商品、接受劳务支付的现金119,227,068.45571,710,965.99448,038,662.1311,243,959.25
  支付给职工以及为职工支付的现金106,690,181.7458,262,574.23314,652,788.51222,811,731.74
  支付的各项税费47,615,883.86244,798,026.27177,425,795.24113,156,905.27
  支付其他与经营活动有关的现金98,247,839456,891,094.17359,242,436.54220,528,164.25
  经营活动现金流出小计371,780,973.011,731,662,660.661,299,359,682.39867,740,760.51
  经营活动产生的现金流量净额186,435,237.27573,765,714.03456,662,073.39327,298,894.2
二、投资活动产生的现金流量:
  收回投资收到的现金208,239,538.34213,966,376.2144,773,736.1710,281,476.48
  取得投资收益收到的现金227,869.194,235,400.98666,832.96544,865.42
  处置固定资产、无形资产和其他长期资产收回的现金净额1,693,0001,002,264.2201,526.85188,076.85
  处置子公司及其他营业单位收到的现金净额-53,955,854.57--
  投资活动现金流入小计210,160,407.53273,159,895.95145,642,095.9811,014,418.75
  购建固定资产、无形资产和其他长期资产支付的现金9,146,315.6548,851,349.2638,768,594.9931,185,757.25
  投资支付的现金207,094,946.26127,807,822.81151,449,511.0624,246,600.96
  投资活动现金流出小计216,241,261.91176,659,172.07190,218,106.0555,432,358.21
  投资活动产生的现金流量净额-6,080,854.3896,500,723.88-44,576,010.07-44,417,939.46
三、筹资活动产生的现金流量:
  取得借款收到的现金-190,000,000190,000,000140,000,000
  收到其他与筹资活动有关的现金-3,982,865.043,982,865.04-
  筹资活动现金流入平衡项目-000
  筹资活动现金流入小计-193,982,865.04193,982,865.04140,000,000
  偿还债务支付的现金170,625245,000,000180,000,00090,000,000
  分配股利、利润或偿付利息支付的现金138,400,009.2229,876,861.02225,225,627.29209,559,835.62
  其中:子公司支付给少数股东的股利、利润-18,000,00015,300,000-
  支付其他与筹资活动有关的现金770,673.5147,157,836.12133,745,772.5960,670,612.42
  筹资活动现金流出小计139,341,307.7622,034,697.14538,971,399.88360,230,448.04
  筹资活动产生的现金流量净额-139,341,307.7-428,051,832.1-344,988,534.84-220,230,448.04
四、汇率变动对现金及现金等价物的影响-31,527.4939,904.7852,353.0750,273.04
五、现金及现金等价物净增加额40,981,547.7242,254,510.5967,149,881.5562,700,779.74
  加:期初现金及现金等价物余额820,512,511.69578,258,001.1578,258,001.1578,258,001.1
  期末现金及现金等价物余额861,494,059.39820,512,511.69645,407,882.65640,958,780.84
补充资料:
  净利润-299,899,277.67-175,188,416.73
  资产减值准备-83,579,791.24-10,010,853.29
  固定资产和投资性房地产折旧-120,970,723.7-60,600,270.96
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-120,970,723.7-60,600,270.96
  无形资产摊销-13,089,266.6-5,948,709.36
  长期待摊费用摊销-567,062.93-286,804.8
  处置固定资产、无形资产和其他长期资产的损失--182,987.15--50,194.26
  固定资产报废损失-278,748.15--16,491.61
  公允价值变动损失--19,004,345.09--419,744.99
  财务费用-1,521,821.11-1,168,645.37
  投资损失--74,038,738.49--992,783.8
  递延所得税-12,201,019.4-1,022,216.45
  其中:递延所得税资产减少-18,025,519.33-1,367,098.32
    递延所得税负债增加--5,824,499.93--344,881.87
  存货的减少-77,561,961.3-49,586,821.67
  经营性应收项目的减少-136,205,335.68-63,764,586.72
  经营性应付项目的增加--73,881,071.81--33,038,387.27
  不涉及现金收支的投资和筹资活动金额其他项目-1,129,560.09--
  现金的期末余额-820,512,511.69-640,958,780.84
  减:现金的期初余额-578,258,001.1-578,258,001.1
  现金及现金等价物的净增加额-242,254,510.59-62,700,779.74
公告日期2026-04-252026-04-252025-10-252025-08-16
审计意见(境内)标准无保留意见
TOP↑